Cargando…

Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways

Altered DNA methylation events contribute to the pathogenesis and progression of metabolic disorders, including nonalcoholic fatty liver disease (NAFLD). Investigations of global DNA methylation patterns in liver biopsies representing severe NAFLD fibrosis have been limited. We used the HumanMethyla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerhard, Glenn S., Malenica, Ivana, Llaci, Lorida, Chu, Xin, Petrick, Anthony T., Still, Christopher D., DiStefano, Johanna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044005/ https://www.ncbi.nlm.nih.gov/pubmed/30005700 http://dx.doi.org/10.1186/s13148-018-0525-9

Ejemplares similares

Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD
por: Johnson, Nicholas D., et al.
Publicado: (2021)

NAFLD in normal weight individuals
por: DiStefano, Johanna K., et al.
Publicado: (2022)

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes
por: Gerhard, Glenn S, et al.
Publicado: (2018)

A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
por: Wood, G. Craig, et al.
Publicado: (2017)

AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p
por: Gerhard, Glenn S., et al.
Publicado: (2019)

Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis
por: Gerhard, Glenn S., et al.
Publicado: (2020)

Hepatic PEMT Expression Decreases with Increasing NAFLD Severity
por: Piras, Ignazio S., et al.
Publicado: (2022)

Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity
por: Gerhard, Glenn S., et al.
Publicado: (2014)

CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
por: Chu, Xin, et al.
Publicado: (2018)

The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women
por: DiStefano, Johanna K.
Publicado: (2023)

Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
por: Miao, Zong, et al.
Publicado: (2021)

The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Hanson, Amanda, et al.
Publicado: (2018)

Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma
por: Castellana, Marco, et al.
Publicado: (2021)

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis
por: Villeret, François, et al.
Publicado: (2023)

Palmitate and Fructose Interact to Induce Human Hepatocytes to Produce Pro-Fibrotic Transcriptional Responses in Hepatic Stellate Cells Exposed to Conditioned Media
por: Piras, Ignazio S., et al.
Publicado: (2020)

The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients
por: Gerhard, Glenn S, et al.
Publicado: (2011)

Compound heterozygous mutations in MASP1 in a deaf child with absent cochlear nerves
por: Kari, Elina, et al.
Publicado: (2017)

Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease
por: Nakatochi, Masahiro, et al.
Publicado: (2017)

An electronic health record-enabled obesity database
por: Wood, G Craig, et al.
Publicado: (2012)

Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
por: Rivera-Esteban, Jesús, et al.
Publicado: (2022)

A de novo SIX1 variant in a patient with a rare nonsyndromic cochleovestibular nerve abnormality, cochlear hypoplasia, and bilateral sensorineural hearing loss
por: Kari, Elina, et al.
Publicado: (2019)

Cirrhosis presenting as Parkinsonism
por: Noone, Mohan L., et al.
Publicado: (2008)

A Patient-Centered Electronic Tool for Weight Loss Outcomes after Roux-en-Y Gastric Bypass
por: Wood, G. Craig, et al.
Publicado: (2014)

A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass
por: Gerhard, Glenn S., et al.
Publicado: (2013)

Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery
por: Still, Christopher D., et al.
Publicado: (2014)

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival
por: Villeret, François, et al.
Publicado: (2022)

THU642 Progression To Cirrhosis And All-cause Mortality Are Increased In Postmenopausal Women With NAFLD
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

Loss of Quaking RNA binding protein disrupts the expression of genes associated with astrocyte maturation in mouse brain
por: Sakers, Kristina, et al.
Publicado: (2021)

Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
por: Türker, Fatih, et al.
Publicado: (2021)

Deciphering the role of aberrant DNA methylation in NAFLD and NASH()
por: Vachher, Meenakshi, et al.
Publicado: (2022)

Development and characterization of microsatellite loci for common raven (Corvus corax) and cross species amplification in other Corvidae
por: Pruett, Christin L., et al.
Publicado: (2015)

“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
por: Hanna, David J., et al.
Publicado: (2021)

Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study
por: Zheng, Melanie, et al.
Publicado: (2023)

Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long‐Term Risks of Congestive Heart Failure
por: Benotti, Peter N., et al.
Publicado: (2017)

Quantitative digital pathology reveals association of cell-specific PNPLA3 transcription with NAFLD disease activity
por: Sandhu, Bynvant, et al.
Publicado: (2019)

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
por: Rada, Patricia, et al.
Publicado: (2020)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
por: Longo, Miriam, et al.
Publicado: (2021)

Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
por: López-Méndez, Iván, et al.
Publicado: (2023)

Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
por: Dooghaie Moghadam, Arash, et al.
Publicado: (2020)

RF17 | P715 Contribution of Low Muscle Mass and Genetic Factors in NAFLD and Liver Cirrhosis
por: Choe, Hun Jee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_laisl8r3ch6bilsds46et9441s